These same changes in the liver – ketone body production from burning fat, along with a rise in eIF4E activity – also occurred when laboratory animals were given a ketogenic diet consisting mostly of ...

A ketogenic diet can interact with certain cancer therapies to block the development of pancreatic cancer in mice, ... blocks eIF4E and the ketogenic pathway so that the body stops metabolizing fat.

They found that a new cancer drug called eFT508, currently in clinical trials, blocks eIF4E and the ketogenic pathway, ...

They discovered that the new cancer drug eFT508, which is currently in clinical trials, effectively blocks eIF4E and the ketogenic pathway, preventing the body from metabolizing fat.

They found that a new cancer drug called eFT508, currently in clinical trials, blocks eIF4E and the ketogenic pathway, preventing the body from metabolizing fat.

By uncovering this previously unknown pathway, the researchers have created an opportunity to revisit longstanding questions about the mechanisms behind the ketogenic diet’s purported benefits. Until ...

They found that a new cancer drug called eFT508, currently in clinical trials, blocks eIF4E and the ketogenic pathway, preventing the body from metabolizing fat.

This pathway, a 'shunt' off the main ketone processing routes, produces compounds that suppress appetite and contribute to ...

Combining eFT508 with a Ketogenic Diet for Pancreatic Cancer Patients They found that a new cancer drug called eFT508, currently in clinical trials, blocks eIF4E and the ketogenic pathway ...

A ketogenic diet can interact with certain cancer therapies to block the development of pancreatic cancer in mice, ... blocks eIF4E and the ketogenic pathway so that the body stops metabolizing fat.

They found that a new cancer drug called eFT508, currently in clinical trials, blocks eIF4E and the ketogenic pathway, preventing the body from metabolizing fat.